Research Peptides: Guides & Analysis
Research peptides are short chains of amino acids supplied for in vitro and laboratory research only, not for human or veterinary use. This hub collects our compound guides, side-by-side comparisons and research analysis.
Evidence-based research guides, scientific articles, and educational resources on BPC-157, Semaglutide, Retatrutide, metabolic research, tissue repair and more. Updated regularly for laboratory and independent research.
Retatrutide Phase 3 Trials: TRIUMPH and TRANSCEND Research Guide
Retatrutide Phase 3 trials (TRIUMPH, TRANSCEND-T2D) test LY3437943, a ~4731 Da triple GLP-1/GIP/glucagon agonist, in obesity and type 2 diabetes research.
MOTS-c FDA Compounding 2026: Mitochondrial Peptide Research Guide
MOTS-c FDA compounding 2026 status affects research access to this 16-amino-acid mitochondrial peptide. Learn what the bulk list means for labs.
PCAC July 2026: Seven Peptides Reviewed for the 503A List
On 23–24 July 2026, FDA’s PCAC agenda listed seven peptides for the 503A bulks list: BPC-157, KPV, TB-500, MOTS-c, emideltide (DSIP), epitalon, and semax. FDA has not posted summary minutes or vote tallies. Selank, GHK-Cu, and kisspeptin-10 were not on that agenda. The meeting did not add any substance to the 503A or 503B list.
Injectable Peptide Regulation Gap 2026: JAMA Research Analysis
Injectable peptide regulation gaps identified in 2026 JAMA research reveal systemic oversight failures affecting lab-grade compound quality, purity verification, and research integrity.
FDA Peptide Ban Reversal 2026: What Researchers Must Know Now
FDA peptide ban reversal could reopen 503B bulk list to cosmetic peptides by Q2 2026, restoring GHK-Cu, Argireline, and Matrixyl for dermatology research.
Antimicrobial Peptides in Cancer Research 2026: Mechanisms & Trials
Antimicrobial peptides cancer research shows LL-37 and defensins trigger immunogenic cell death, inhibit angiogenesis, and enhance checkpoint blockade in 2026 pre-clinical models.
FDA Peptide Ban List 2025: What Research Labs Need to Know
FDA peptide ban list 2025 explained: which compounds are restricted, why compounding rules changed, and how research labs can maintain compliant procurement.